Drug General Information
Drug ID
D0U4TY
Former ID
DNC010609
Drug Name
4-cycloheptyl-6-propylpyrimidine-2-carbonitrile
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530717]
Structure
Download
2D MOL

3D MOL

Formula
C15H21N3
Canonical SMILES
CCCC1=NC(=NC(=C1)C2CCCCCC2)C#N
InChI
1S/C15H21N3/c1-2-7-13-10-14(18-15(11-16)17-13)12-8-5-3-4-6-9-12/h10,12H,2-9H2,1H3
InChIKey
UOAUUFFKQMFGTJ-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Cathepsin S Target Info Inhibitor [530717]
Cathepsin K Target Info Inhibitor [530717]
KEGG Pathway Lysosome
Phagosome
Antigen processing and presentation
Tuberculosishsa04142:Lysosome
Osteoclast differentiation
Toll-like receptor signaling pathway
Rheumatoid arthritis
NetPath Pathway Leptin Signaling Pathway
IL2 Signaling PathwayNetPath_7:TGF_beta_Receptor Signaling Pathway
RANKL Signaling Pathway
IL2 Signaling Pathway
Reactome Endosomal/Vacuolar pathway
Degradation of the extracellular matrix
Trafficking and processing of endosomal TLR
Assembly of collagen fibrils and other multimeric structures
MHC class II antigen presentationR-HSA-1442490:Collagen degradation
Activation of Matrix Metalloproteinases
MHC class II antigen presentation
WikiPathways Class I MHC mediated antigen processing & presentation
Trafficking and processing of endosomal TLRWP2018:RANKL/RANK Signaling Pathway
Osteoclast Signaling
References
Ref 530717Bioorg Med Chem Lett. 2010 Mar 1;20(5):1524-7. Epub 2010 Jan 25.Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.
Ref 530717Bioorg Med Chem Lett. 2010 Mar 1;20(5):1524-7. Epub 2010 Jan 25.Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.